Chronic inflammation leads to an impairment of insulin signaling, thereby contributing to the development of hepatic insulin resistance and the progression of NAFLD (Perry et al. 2015; Saberi et al. 2009; Tilg and Hotamisligil 2006). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.